CN103103175A - 新型腈水合酶 - Google Patents
新型腈水合酶 Download PDFInfo
- Publication number
- CN103103175A CN103103175A CN2012105742761A CN201210574276A CN103103175A CN 103103175 A CN103103175 A CN 103103175A CN 2012105742761 A CN2012105742761 A CN 2012105742761A CN 201210574276 A CN201210574276 A CN 201210574276A CN 103103175 A CN103103175 A CN 103103175A
- Authority
- CN
- China
- Prior art keywords
- sequence
- sequence number
- nitrile hydratase
- replaced
- subunit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010024026 Nitrile hydratase Proteins 0.000 title claims abstract description 623
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 438
- 238000000034 method Methods 0.000 claims abstract description 209
- 150000001413 amino acids Chemical class 0.000 claims abstract description 189
- 238000006467 substitution reaction Methods 0.000 claims abstract description 186
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 127
- -1 nitrile compound Chemical class 0.000 claims abstract description 67
- 239000013612 plasmid Substances 0.000 claims description 416
- 235000001014 amino acid Nutrition 0.000 claims description 373
- 230000009466 transformation Effects 0.000 claims description 131
- 238000004519 manufacturing process Methods 0.000 claims description 126
- 238000002360 preparation method Methods 0.000 claims description 106
- 230000008859 change Effects 0.000 claims description 100
- 235000015097 nutrients Nutrition 0.000 claims description 77
- 238000006073 displacement reaction Methods 0.000 claims description 63
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 238000005755 formation reaction Methods 0.000 claims description 14
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 208
- 230000035772 mutation Effects 0.000 abstract description 166
- 102000004190 Enzymes Human genes 0.000 abstract description 111
- 108090000790 Enzymes Proteins 0.000 abstract description 111
- 125000000539 amino acid group Chemical group 0.000 abstract description 89
- 238000003780 insertion Methods 0.000 abstract description 6
- 230000037431 insertion Effects 0.000 abstract description 6
- 241000187602 Pseudonocardia thermophila Species 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 691
- 108020004414 DNA Proteins 0.000 description 404
- 229940024606 amino acid Drugs 0.000 description 317
- 238000012360 testing method Methods 0.000 description 266
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical class N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 178
- 229920000936 Agarose Polymers 0.000 description 159
- 238000000605 extraction Methods 0.000 description 159
- 239000000047 product Substances 0.000 description 138
- 238000000246 agarose gel electrophoresis Methods 0.000 description 130
- 238000012163 sequencing technique Methods 0.000 description 119
- 108020004707 nucleic acids Proteins 0.000 description 118
- 150000007523 nucleic acids Chemical class 0.000 description 118
- 102000039446 nucleic acids Human genes 0.000 description 118
- 230000036961 partial effect Effects 0.000 description 118
- 239000012295 chemical reaction liquid Substances 0.000 description 117
- 238000000137 annealing Methods 0.000 description 116
- 230000004544 DNA amplification Effects 0.000 description 114
- 230000004087 circulation Effects 0.000 description 114
- 101150007692 DOA4 gene Proteins 0.000 description 112
- 229940088598 enzyme Drugs 0.000 description 110
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 92
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 82
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 73
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 70
- 239000000243 solution Substances 0.000 description 68
- 108090000765 processed proteins & peptides Proteins 0.000 description 67
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 65
- 210000004027 cell Anatomy 0.000 description 65
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 60
- 238000012795 verification Methods 0.000 description 58
- 229920001184 polypeptide Polymers 0.000 description 54
- 102000004196 processed proteins & peptides Human genes 0.000 description 54
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 50
- 239000000758 substrate Substances 0.000 description 50
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 44
- 238000013467 fragmentation Methods 0.000 description 44
- 238000006062 fragmentation reaction Methods 0.000 description 44
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 39
- 230000001954 sterilising effect Effects 0.000 description 38
- 239000007788 liquid Substances 0.000 description 31
- 229910052697 platinum Inorganic materials 0.000 description 30
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 29
- 238000005119 centrifugation Methods 0.000 description 29
- 239000002609 medium Substances 0.000 description 29
- 229920002684 Sepharose Polymers 0.000 description 28
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 24
- 239000006152 selective media Substances 0.000 description 24
- 239000000155 melt Substances 0.000 description 18
- 238000002844 melting Methods 0.000 description 18
- 230000008018 melting Effects 0.000 description 18
- 238000012986 modification Methods 0.000 description 17
- 230000004048 modification Effects 0.000 description 17
- 238000005520 cutting process Methods 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 241000894007 species Species 0.000 description 16
- 238000012545 processing Methods 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000008034 disappearance Effects 0.000 description 11
- 241001478240 Coccus Species 0.000 description 10
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 10
- 239000012190 activator Substances 0.000 description 10
- 125000004429 atom Chemical group 0.000 description 10
- ADVPTQAUNPRNPO-REOHCLBHSA-N 3-sulfino-L-alanine Chemical compound OC(=O)[C@@H](N)C[S@@](O)=O ADVPTQAUNPRNPO-REOHCLBHSA-N 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 9
- 238000009413 insulation Methods 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 241000208202 Linaceae Species 0.000 description 8
- 235000004431 Linum usitatissimum Nutrition 0.000 description 8
- 238000012869 ethanol precipitation Methods 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 7
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 7
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 7
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- FXIRVRPOOYSARH-REOHCLBHSA-N S-hydroxy-L-cysteine Chemical compound OC(=O)[C@@H](N)CSO FXIRVRPOOYSARH-REOHCLBHSA-N 0.000 description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 6
- ADVPTQAUNPRNPO-UHFFFAOYSA-N alpha-amino-beta-sulfino-propionic acid Natural products OC(=O)C(N)CS(O)=O ADVPTQAUNPRNPO-UHFFFAOYSA-N 0.000 description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 6
- 235000008521 threonine Nutrition 0.000 description 6
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 229960002989 glutamic acid Drugs 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 230000000869 mutational effect Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 108010047524 Deoxyribonuclease HindIII Proteins 0.000 description 3
- 241001131785 Escherichia coli HB101 Species 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000002427 irreversible effect Effects 0.000 description 3
- 150000003588 threonines Chemical class 0.000 description 3
- 230000005030 transcription termination Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 108091027305 Heteroduplex Proteins 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 239000006035 Tryptophane Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241001037822 Bacillus bacterium Species 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 101100412856 Mus musculus Rhod gene Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000187603 Pseudonocardia Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 108010046685 Rho Factor Proteins 0.000 description 1
- 101100348564 Rhodococcus rhodochrous nhhB gene Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 101100242191 Tetraodon nigroviridis rho gene Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- ARPLKSKOWFTTTQ-UHFFFAOYSA-L cobalt(2+);dichloride;dihydrate Chemical class O.O.Cl[Co]Cl ARPLKSKOWFTTTQ-UHFFFAOYSA-L 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- NKKMVIVFRUYPLQ-NSCUHMNNSA-N crotononitrile Chemical compound C\C=C\C#N NKKMVIVFRUYPLQ-NSCUHMNNSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 101150008784 nhhA gene Proteins 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940093916 potassium phosphate Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01084—Nitrile hydratase (4.2.1.84)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002368360A JP2004194588A (ja) | 2002-12-19 | 2002-12-19 | 新規なニトリルヒドラターゼ |
| JP368360/2002 | 2002-12-19 | ||
| JP379280/2003 | 2003-11-10 | ||
| JP2003379280 | 2003-11-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2003801069930A Division CN1729288A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103103175A true CN103103175A (zh) | 2013-05-15 |
Family
ID=32684188
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105742761A Pending CN103103175A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
| CN2010101672031A Pending CN101892211A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
| CN2012105742117A Pending CN103215242A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
| CNA2003801069930A Pending CN1729288A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101672031A Pending CN101892211A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
| CN2012105742117A Pending CN103215242A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
| CNA2003801069930A Pending CN1729288A (zh) | 2002-12-19 | 2003-12-15 | 新型腈水合酶 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7595184B2 (enExample) |
| EP (1) | EP1586637B1 (enExample) |
| JP (1) | JP2004194588A (enExample) |
| KR (5) | KR100785549B1 (enExample) |
| CN (4) | CN103103175A (enExample) |
| AU (2) | AU2003289338A1 (enExample) |
| WO (1) | WO2004056990A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112322606A (zh) * | 2020-11-20 | 2021-02-05 | 江南大学 | 一种腈水合酶突变体及其应用 |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1767624B1 (en) * | 2004-05-26 | 2013-11-06 | Mitsubishi Rayon Co., Ltd. | Improved nitrile hydratase |
| EP1842907A1 (en) | 2006-04-07 | 2007-10-10 | B.R.A.I.N. Ag | A group of novel enantioselective microbial nitrile hydratases with broad substrate specificity |
| JP5069032B2 (ja) * | 2007-04-04 | 2012-11-07 | ダイヤニトリックス株式会社 | 改良型ニトリルヒドラターゼ |
| KR101532467B1 (ko) * | 2008-11-14 | 2015-07-06 | 미쓰이 가가쿠 가부시키가이샤 | 니트릴 히드라타아제 변이체 |
| JP5532618B2 (ja) * | 2009-01-30 | 2014-06-25 | 三菱レイヨン株式会社 | 改良型ニトリルヒドラターゼ及びその製造方法 |
| EP2426210A4 (en) * | 2009-04-30 | 2016-12-21 | Mitsui Chemicals Inc | PROCESS FOR PRODUCING 3-MERCAPTOPROPIONIC ACID OR SALT THEREOF |
| KR20140006052A (ko) | 2011-05-31 | 2014-01-15 | 미쯔비시 레이온 가부시끼가이샤 | 개량형 니트릴 히드라타제 |
| CN104531654B (zh) * | 2011-06-07 | 2018-06-12 | 三菱化学株式会社 | 改良型腈水合酶 |
| CN102517271B (zh) * | 2011-12-13 | 2013-04-03 | 清华大学 | 一种突变腈水合酶 |
| EP3153582B1 (en) | 2014-06-06 | 2020-06-17 | Mitsubishi Chemical Corporation | Improved nitrile hydratase |
| CN104725476B (zh) * | 2015-03-31 | 2018-10-16 | 清华大学 | 一种钩状结构寡肽及其应用 |
| CN110139930B (zh) * | 2016-12-28 | 2023-08-25 | 三井化学株式会社 | 突变型腈水合酶及其应用 |
| KR20190049109A (ko) | 2017-11-01 | 2019-05-09 | (주)대화정공 | 풀리 제조방법 |
| KR102146408B1 (ko) | 2019-04-08 | 2020-08-21 | (주)대화정공 | 단류선 개선을 위해 압연롤러를 이용한 자동차 댐퍼풀리 제조방법 |
| KR102068615B1 (ko) | 2019-04-08 | 2020-01-21 | (주)대화정공 | 자동차 댐퍼풀리 제조방법 |
| CN111690675B (zh) * | 2019-08-01 | 2022-07-19 | 安徽瑞邦生物科技有限公司 | 一种表达腈水合酶突变体的重组菌及其制备方法和应用 |
| CN112522245A (zh) * | 2020-12-09 | 2021-03-19 | 江南大学 | 一种腈水合酶氨基酸基序的改造及其应用 |
| CN113151234B (zh) * | 2021-04-13 | 2022-08-12 | 浙江工业大学 | 腈水合酶赖氨酸突变体hba-k2h2r、编码基因及应用 |
| CN113444714B (zh) * | 2021-07-29 | 2022-06-21 | 浙江大学杭州国际科创中心 | 一种β亚基突变的腈水合酶突变体及其应用 |
| CN114317507B (zh) * | 2021-11-30 | 2024-07-02 | 清华大学 | 腈水合酶突变体及其应用 |
| KR20250011936A (ko) * | 2022-06-30 | 2025-01-22 | 미쓰이 가가쿠 가부시키가이샤 | 변이형 나이트릴 하이드라타제, 그 변이형 나이트릴 하이드라타제를 코딩하는 핵산, 그 핵산을 포함하는 벡터 및 형질 전환체, 그 변이형 나이트릴 하이드라타제의 제조 방법, 및 아마이드 화합물의 제조 방법 |
| CN115772514B (zh) * | 2022-11-03 | 2025-03-04 | 无锡新晨宇生物工程有限公司 | 一种腈水合酶底物通道氨基酸基序的改造用于肉桂酰胺的制备 |
| EP4600368A1 (en) * | 2024-02-09 | 2025-08-13 | Adisseo France S.A.S. | A method for enzymatic production of an amide compound |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09275978A (ja) * | 1996-02-14 | 1997-10-28 | Mitsui Toatsu Chem Inc | 新規なニトリルヒドラターゼ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD274631A5 (de) * | 1987-09-18 | 1989-12-27 | Kk | Verfahren zur biologischen herstellung von amiden |
| AU627648B2 (en) | 1990-02-28 | 1992-08-27 | Teruhiko Beppu | Dna fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant |
| JPH0856684A (ja) | 1994-08-16 | 1996-03-05 | Mitsui Toatsu Chem Inc | 微生物によるアミド化合物の製造法 |
| CN1243825C (zh) * | 1996-02-14 | 2006-03-01 | 三井化学株式会社 | 新型腈水合酶 |
| JP3408737B2 (ja) | 1998-03-16 | 2003-05-19 | 三井化学株式会社 | ニトリルヒドラターゼの活性化に関与するタンパク質及びそれをコードする遺伝子 |
-
2002
- 2002-12-19 JP JP2002368360A patent/JP2004194588A/ja active Pending
-
2003
- 2003-12-15 WO PCT/JP2003/016014 patent/WO2004056990A1/ja not_active Ceased
- 2003-12-15 KR KR1020067026865A patent/KR100785549B1/ko not_active Expired - Lifetime
- 2003-12-15 EP EP03780752.6A patent/EP1586637B1/en not_active Expired - Lifetime
- 2003-12-15 KR KR1020067026866A patent/KR100785548B1/ko not_active Expired - Lifetime
- 2003-12-15 KR KR1020057011335A patent/KR100825147B1/ko not_active Expired - Lifetime
- 2003-12-15 CN CN2012105742761A patent/CN103103175A/zh active Pending
- 2003-12-15 AU AU2003289338A patent/AU2003289338A1/en not_active Abandoned
- 2003-12-15 CN CN2010101672031A patent/CN101892211A/zh active Pending
- 2003-12-15 KR KR1020077015994A patent/KR100794001B1/ko not_active Expired - Lifetime
- 2003-12-15 KR KR1020077024119A patent/KR100819228B1/ko not_active Expired - Lifetime
- 2003-12-15 US US10/539,560 patent/US7595184B2/en not_active Expired - Lifetime
- 2003-12-15 CN CN2012105742117A patent/CN103215242A/zh active Pending
- 2003-12-15 CN CNA2003801069930A patent/CN1729288A/zh active Pending
-
2010
- 2010-06-28 AU AU2010202683A patent/AU2010202683B2/en not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09275978A (ja) * | 1996-02-14 | 1997-10-28 | Mitsui Toatsu Chem Inc | 新規なニトリルヒドラターゼ |
Non-Patent Citations (1)
| Title |
|---|
| AKIMASA MIYANAGA,ET AL: "Crystal Structure of Cobalt-Containing Nitrile Hydratase", 《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112322606A (zh) * | 2020-11-20 | 2021-02-05 | 江南大学 | 一种腈水合酶突变体及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20070009985A1 (en) | 2007-01-11 |
| AU2010202683A1 (en) | 2010-07-15 |
| KR20050089972A (ko) | 2005-09-09 |
| EP1586637A4 (en) | 2008-03-19 |
| WO2004056990A1 (ja) | 2004-07-08 |
| AU2003289338A1 (en) | 2004-07-14 |
| KR100819228B1 (ko) | 2008-04-03 |
| KR20070087054A (ko) | 2007-08-27 |
| EP1586637A1 (en) | 2005-10-19 |
| AU2010202683B2 (en) | 2012-01-19 |
| KR20070110146A (ko) | 2007-11-15 |
| JP2004194588A (ja) | 2004-07-15 |
| KR20070007393A (ko) | 2007-01-15 |
| EP1586637B1 (en) | 2014-02-26 |
| US7595184B2 (en) | 2009-09-29 |
| KR100785548B1 (ko) | 2007-12-12 |
| CN101892211A (zh) | 2010-11-24 |
| KR100825147B1 (ko) | 2008-04-24 |
| CN1729288A (zh) | 2006-02-01 |
| KR20070011620A (ko) | 2007-01-24 |
| KR100794001B1 (ko) | 2008-01-10 |
| CN103215242A (zh) | 2013-07-24 |
| KR100785549B1 (ko) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103103175A (zh) | 新型腈水合酶 | |
| KR101483344B1 (ko) | L-라이신 생산능을 갖는 미생물을 이용하여 l-라이신을 생산하는 방법 | |
| US7294493B2 (en) | Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids | |
| EP1647593B1 (en) | Method for producing l-histidine using bacteria of the enterobacteriaceae family | |
| US5910432A (en) | Nitrile hydratase | |
| JP2001046067A (ja) | 好熱性バチルス属細菌由来のl−リジン生合成系遺伝子 | |
| EP1602722A1 (en) | Process for producing microbial transglutaminase | |
| CN102216455A (zh) | 腈水合酶突变体 | |
| KR102143964B1 (ko) | 신규한 분지쇄 아미노산 아미노트랜스퍼라제 변이체 및 이를 이용한 류신 생산방법 | |
| EP0943686B1 (en) | Protein participating in activation of nitrile hydratase,gene,plasmid and a process for producing an amide | |
| CN104160015B (zh) | 生产喹啉酸的重组微生物及利用该微生物的喹啉酸生产方法 | |
| CN116648504A (zh) | 生产腐胺的微生物和利用其生产腐胺的方法 | |
| CN100406553C (zh) | 生产D-N-氨基甲酰基-α-氨基酸的方法 | |
| JP4216700B2 (ja) | ニトリルヒドラターゼ活性を有する酵素の改変方法 | |
| Shi et al. | Cloning of the nitrile hydratase gene from Nocardia sp. in Escherichia coli and Pichia pastoris and its functional expression using site-directed mutagenesis | |
| CA2252616C (en) | Biocatalysts with amine acylase activity | |
| CN115003807A (zh) | 新半胱氨酸亚磺酸脱硫酶变体及使用其生产l-缬氨酸的方法 | |
| JP4627039B2 (ja) | アミダーゼ活性を有するポリペプチド及びその遺伝子 | |
| JP2007129908A (ja) | システインプロテアーゼ及びその利用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130515 |